Central artery stiffness, neuropsychological function, and cerebral perfusion in sedentary and endurance-trained middle-aged adults

Journal of Hypertension

Volumn 31, Issue 12, 2013, Pages 2400-2409

  Tarumi, Takashi ^a   Gonzales, Mitzi M ^b   Fallow, Bennett ^a   Nualnim, Nantinee ^a   Pyron, Martha ^a,c   Tanaka, Hirofumi ^a   Haley, Andreana P ^b  

^a Department of Kinesiology and Health Education ^*  (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c Medicine in Motion   (United States)

Author keywords

cerebral blood flow; cognition; maximal aerobic capacity; physical exercise

Indexed keywords

ADULT; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATTENTION; BLOOD PRESSURE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDURANCE TRAINING; EXECUTIVE FUNCTION; FEMALE; HUMAN; MALE; MEMORY; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULSE WAVE; SEDENTARY LIFESTYLE;

FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHYSICAL ENDURANCE; SEDENTARY LIFESTYLE; VASCULAR STIFFNESS;

EID: 84888088025     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328364decc     Document Type: Article

References (57)

1. Henskens LH, Kroon AA, van Oostenbrugge RJ, Gronenschild EH, Fuss-Lejeune MM, Hofman PA, et al. Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients. Hypertension 2008; 52:1120-1126.
2. Scuteri A, Tesauro M, Appolloni S, Preziosi F, Brancati AM, Volpe M. Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens 2007; 25:1035-1040.
3. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46:200-204.
4. Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol 2008; 105:1652-1660.
5. Tarumi T, Shah F, Tanaka H, Haley AP. Association between central elastic artery stiffness and cerebral perfusion in deep subcortical gray and white matter. Am J Hypertens 2011; 24:1108-1113.
6. Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson O, et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility-Reykjavik study. Brain 2011; 134:3398-3407.
7. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 2005; 57:789-794.
8. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol 2002; 1:426-436.
9. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 2006; 5:735-741.
10. Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011; 77:461-468.
11. Rovio S, Kareholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J, et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 2005; 4:705-711.
12. Tanaka H, Dinenno FA, Monahan KD, Clevenger CM, DeSouza CA, Seals DR. Aging, habitual exercise, and dynamic arterial compliance. Circulation 2000; 102:1270-1275.
13. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985; 10:141-146.
14. American College of Sports Medicine. Guidelines for exercise testing and prescription. Baltimore: Lippincott Williams & Wilkins; 2006.
15. Cortez-Cooper MY, Supak JA, Tanaka H. A new device for automatic measurements of arterial stiffness and ankle-brachial index. Am J Cardiol 2003; 91:1519-1522; A9.
16. Sugawara J, Hayashi K, Yokoi T, Tanaka H. Age-associated elongation of the ascending aorta in adults. JACC Cardiovasc Imaging 2008; 1:739-748.
17. O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002; 15:426-444.
18. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
19. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992; 23:37-45.
20. Kim SG. Quantification of relative cerebral blood flow change by flowsensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn Reson Med 1995; 34:293-301.
21. Liu TT, Brown GG. Measurement of cerebral perfusion with arterial spin labeling: part 1. Methods. J Int Neuropsychol Soc 2007; 13:517-525.
22. Wang J, Qiu M, Constable RT. In vivo method for correcting transmit/receive nonuniformities with phased array coils. Magn Reson Med 2005; 53:666-674.
23. Chalela JA, Alsop DC, Gonzalez-Atavales JB, Maldjian JA, Kasner SE, Detre JA. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke 2000; 31:680-687.
24. De Reuck J. The human periventricular arterial blood supply and the anatomy of cerebral infarctions. Eur Neurol 1971; 5:321-334.
25. Rowbotham GF, Little E. Circulations of the cerebral hemispheres. Br J Surg 1965; 52:8-21.
26. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain 3-D proportional system: an approach to cerebral imaging. New York: Thieme Medical Publishers; 1988.
27. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996; 29:162-173.
28. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
29. Wechsler D. Wechsler Test of Adult Reading: WTAR. Psychological Corp; 2001.
30. Park DC, Reuter-Lorenz P. The adaptive brain: aging and neurocognitive scaffolding. Annu Rev Psychol 2009; 60:173-196.
31. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test: Adult version. San Antonio, TX: The Psychological Corporation; 1987.
32. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958; 8:271-276.
33. Ruff RM, Light RH, Parker SB, Levin HS. Benton Controlled Oral Word Association Test: reliability and updated norms. Arch Clin Neuropsychol 1996; 11:329-338.
34. Wechsler D. WAIS-III administration and scoring manual. San Antonio, TX: The Psychological Corporation; 1997.
35. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess 1996; 67:588-597.
36. Spielberger CD, Sydeman SJ. State-Trait Anxiety Inventory and State-Trait Anger Expression Inventory. In: Maruish ME, editor. The use of psychological testing for treatment planning and outcome assessment. Hillsdale, NJ: Lawrence Erlbaum Associates; 1994.
37. Hays RD, Stewart AL. Sleep measures. In: Stewart AL, Ware JE, editors. Measuring functioning and well being: The Medical Outcomes Study approach. Durham, NC: Duke University Press; 1992.
38. Eric R, Kandel JHS, Thomas M. Jessel. Principles of neural science. New York: McGraw-Hill; 2000.
39. Seals DR, Walker AE, Pierce GL, Lesniewski LA. Habitual exercise and vascular ageing. J Physiol 2009; 587:5541-5549.
40. Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008; 300:1027-1037.
41. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990; 13:171-182.
42. Okamoto Y, Yamamoto T, Kalaria RN, Senzaki H, Maki T, Hase Y, et al. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol 2012; 123:381-394.
43. McEntee WJ, Crook TH. Glutamate: its role in learning, memory, and the aging brain. Psychopharmacology (Berl) 1993; 111:391-401.
44. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1:623-634.
45. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003; 348:1333-1341.
46. Haley AP, Gonzales MM, Tarumi T, Miles SC, Goudarzi K, Tanaka H. Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome. Metab Brain Dis 2010; 25:397-405.
47. Haley AP, Gonzales MM, Tarumi T, Tanaka H. Subclinical vascular disease and cerebral glutamate elevation in metabolic syndrome. Metab Brain Dis 2012; 27:513-520.
48. Rodrigue KM, Kennedy KM, Devous MD Sr, Rieck JR, Hebrank AC, Diaz-Arrastia R, et al. beta-Amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology 2012; 78:387-395.
49. Head D, Bugg JM, Goate AM, Fagan AM, Mintun MA, Benzinger T, et al. Exercise engagement as a moderator of the effects of APOE genotype on amyloid deposition. Arch Neurol 2012; 69:636-643.
50. Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 2010; 330:1774.
51. Zhang X, Zhou K, Wang R, Cui J, Lipton SA, Liao FF, et al. Hypoxiainducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem 2007; 282:10873-10880.
52. Hadaczek P, Yamashita Y, Mirek H, Tamas L, Bohn MC, Noble C, et al. The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Mol Ther 2006; 14:69-78.
53. Schley D, Carare-Nnadi R, Please CP, Perry VH, Weller RO. Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J Theor Biol 2006; 238:962-974.
54. Weller RO, Yow HY, Preston SD, Mazanti I, Nicoll JA. Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease. Ann N Y Acad Sci 2002; 977:162-168.
55. Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 2007; 62:229-234.
56. Gonzales MM, Tarumi T, Eagan DE, Tanaka H, Vaghasia M, Haley AP. Indirect effects of elevated body mass index on memory performance through altered cerebral metabolite concentrations. Psychosom Med 2012; 74:691-698.
57. Gonzales MM, Tarumi T, Miles SC, Tanaka H, Shah F, Haley AP. Insulin sensitivity as a mediator of the relationship between BMI and working memory-related brain activation. Obesity (Silver Spring) 2010; 18:2131-2137.